ABSTRACT We examined whether or not subsets of patients with complex ventricular arrhythmias after myocardial infarction are at high risk with respect to 1 year mortality after hospital discharge. Based on previous studies showing increased risk for those with non-Q wave infarcts, we hypothesized that complex PVCs (premature ventricular complexes) in this group might be associated with a poorer prognosis than complex PVCs in patients with Q wave infarcts. Seven hundred seventy-seven patients entering our study with acute infarction were followed prospectively for 1 year after undergoing a predischarge 24 hr ambulatory electrocardiographic examination. Patients were classified by electrocardiographic criteria into the following groups: Non-Q wave (n = 191), Q wave anterior (n = 261), and Q wave inferior infarction (n = 325). The following arrhythmias were classified as complex: multiform PVCs, couplets, and ventricular tachycardia. Sixty-two percent of patients with non-Q wave infarcts who did not survive 1 year had complex PVCs, compared with 32% of survivors (p < .01). No differences were seen in the Q wave subgroup. The survival for patients with Q wave and non-Q wave infarction without complex PVCs were nearly identical at 1 year (93% and 90%), whereas in patients with complex PVCs survival for those with Q wave and non-Q wave infarction was 92% and 76%, respectively (p < .001). Of those with non-Q wave infarction, only 4% of nonsurvivors were free of any PVCs, as compared with 28% of nonsurvivors in the Q wave group (p < .02). Stepwise linear discrimination analysis revealed that complex PVCs were independent of ejection fraction in those with non-Q wave infarction, but were closely associated with ejection fraction in those with Q wave infarction. Thus, the presence of complex PVCs at the time of hospital discharge is an important predictor of 1 year mortality in the presence of non-Q wave, but not Q wave infarction. Circulation 72, No. 5, 963-970, 1985. 
RISK STRATIFICATION during the course of acute myocardial infarction may identify patients who are subsequently at high risk for recurrent infarction or death afer recovery. Recognition of high-risk patients may permit specific interventions to be directed toward the factors responsible. Although the presence of complex ventricular arrhythmias recorded in the late hospital phase of acute infarction have been a strong predictor of subsequent mortality,' 1-2 attempts to improve survival by pharmacologic suppression have resulted in little success. [13] [14] [15] It seems possible that if subsets of patients with complex arrhythmias who are at particularly high risk can be identified, treatment could be selectively aimed at such groups. Although non-Q wave and Q wave infarctions as classified by electrocardiography cannot always be differentiated anatomically, it is clear that they differ clinically and prognostically. 16. 17 Data suggest that patients with non-Q wave infarction, despite an initially favorable prognosis, have a long-term mortality similar to or greater than that of patients with Q wave infarction. 18 19 Recently we have suggested that a non-Q wave infarction may be an unstable event and that variables such as infarct extension during the course of the acute infarction may be markers for late mortality. 20 21 Accordingly, the present study was undertaken to test the hypothesis that complex PVCs (premature ventricular complexes) occurring in the late hospital phase of acute infarction signify a poorer prognosis for patients with non-Q wave infarction compared with the prognosis for those with Q wave infarction.
Methods
Patients. The study group consisted of 1783 patients with acute infarction who were admitted to the hospital within 24 hr after onset of symptoms. Of the 1658 patients eventually discharged from the hospital, 1406 had been followed for 1 year at the time of the study. Of this group, 777 patients underwent predischarge 24 hr ambulatory electrocardiographic (ECG) monitoring, and only this group was analyzed in this study for 1 year outcome. Ambulatory ECG monitoring was not required as part of our protocol and its performance was at the discretion of the attending physician. This could have led to some bias to- ward ECG monitoring in more gravely ill patients. However, statistical analysis comparing this group with the group of patients who did not undergo predischarge ECG monitoring showed no differences in arrhythmias in the intensive care unit, discharge ejection fraction, or 1 year survival. However, there were higher peak creatine kinase (CK) levels, a longer stay in the intensive care unit, and more evidence of heart failure while in the hospital in the patients electrocardiographically monitored.
Q wave infarction was diagnosed by development of pathologic Q waves (as described below) and at least one of the following: (1) chest pain considered characteristic of myocardial ischemia, and (2) elevation of total creatine kinase. Q waves acceptable for diagnosis were as follows: (1) 7%, p = NS). Among patients with complex PVCs, the 1 year mortality in the non-Q wave group was 27% vs 9% in the Q wave group (p < .0 1). Sixty-five variables were examined for association with complex PVCs in the Q wave and non-Q wave categories. Prior history of angina pectoris, myocardial infarction, and heart failure were not associated with complex PVCs in either group. Peak CK levels were higher in patients with Q wave infarctions, but were not significantly higher in those with complex PVCs in either group (table 1) . There was no association between early arrhythmias in the coronary care unit and subsequent complex PVCs in either the Q wave or non-Q wave group. In the Q wave group, complex PVCs were associated with a significantly higher incidence of postinfarction left ventricular failure than that in the non-Q wave group, as evidenced by the occurrence of an S3 gallop (56% vs 45%, p < .01), bibasilar rales (73% vs 54%, p < .001), rales above scapulae ( 1% vs 2%, p < .05), and increased cardiothoracic ratio (0.49 + 0.05 vs 0.47 ± 0.05, p < .01). In the non-Q wave group, there was no significant association between complex PVCs and heart failure (table 1) .
Complex PVCs were present in 39% of the patients with non-Q wave infarctions who survived 1 year (n = 126) (figure 1), while in those patients who did not survive one year (n = 26), complex PVCs occurred in 69% (p < .01). No such differences between survivors and nonsurvivors with respect to complex PVCs were seen in the anterior or inferior Q wave infarct groups. The cumulative survival curves beginning at discharge for patients with Q wave and non-Q wave infarctions with and without complex PVCs are illustrated in figure 2. In patients without complex PVCs (figure 2, A), the survival curves for patients with Q wave infarctions and the curves for those with non-Q wave infarctions were not significantly different, with a 1 year survival of 93% for the Q wave.
(inferior = 95%, anterior = 92%) and of 91% for the non-Q wave group. However, when survival was compared among patients with complex PVCs, signifi- Figure 3 shows the breakdown of arrhythmias detected by 24 ejection fraction in the analysis adds only 5% to predicted mortality over 1 year. The inset of figure 4 separates patients with and without complex PVCs into groups with normal and low ejection fractions. In the Q wave group, patients with complex PVCs were equally divided into the groups of those with ejection fractions less than and greater than 45%. Among those with non-Q wave infarctions and complex PVCs, twice as many patients had ejection fractions greater than 45%.
Multivariate analysis of predictors of mortality.
Stepwise linear discriminant analysis was performed to evaluate independent contributions of ventricular arrhythmias and other variables to postinfarction mortality. No independent contribution to mortality could be attributed to ejection fraction in the non-Q wave group. In this group, the combination of complex PVCs, age, and pulmonary congestion predicted 74% of subsequent deaths. As expected, in contrast to the case in the non-Q wave group, there was no independent influence of complex PVCs on mortality. In the group of patients with Q wave infarction and PVCs the combination of ejection fraction, radiographic pulmonary congestion, and rales above the scapulae predicted 88% of subsequent deaths.
Complex PVCs and antiarrhythmic therapy at discharge.
As can be seen in numbers of patients in each group discharged on antiarrhythmic medication preclude accurate statistical assessment of the effect of this variable on survival. However, among those discharged on antiarrhythmic therapy, there was a trend toward increased 1 year survival in patients with non-Q wave infarction compared with that in patients with Q wave infarction. Thus, of the 17 patients with non-Q wave infarction discharged on therapy, 11 were dead after 1 year, compared with 21 of 24 patients with Q wave infarction similarly followed and on therapy (p = .08).
Discussion
The present study emphasizes the importance of complex PVCs occurring in the late hospital phase of acute myocardial infarction in predicting late cardiac death after non-Q wave myocardial infarction. In patients with Q wave infarction, complex PVCs alone were not associated with increased late mortality. In agreement with Moss28 and Vismara et al," we found no relationship between PVCs in the coronary care unit and the occurrence of similar arrhythmias on ambulatory recordings 1 to 3 weeks later in either group.
One of the first studies to show an association between ventricular arrhythmias after recovery from myocardial infarction and late cardiac death was the coronary drug project,'2 which reported that the presence of one or more PVCs on a 12-lead electrocardiogram was associated with an increased risk of sudden death over the ensuing 2 to 5 years. More recently, The results of the present study strongly suggest that complex PVCs in the recovery phase of acute infarction indicate high-risk status only in patients with non-Q wave infarction. The 1 year survival for these patients was 73%, compared with 90% for the Q wave group (p < .01). Few other studies have examined this relationship. Vismara et al. " followed 64 patients who had a 10 hr ambulatory ECG recording before hospital discharge after acute infarction. Of the 12 patients who subsequently died, eight of whom had complex PVCs, there was no difference in the incidence of Q wave and non-Q wave infarctions. However, the small number of patients in that study severely limited the possibility of distinguishing between the two infarct categories. Davis et al.34 followed 940 patients with myocardial infarction for 12 to 60 months and found that the combination of anterior infarction, left ventricular dysfunction, and PVCs identified a high-risk subset with a 6 month mortality of 15%. Patients with non-Q wave infarctions were not analyzed separately, and the above combination would be expected to yield a high proportion of patients with a poor ejection fraction.
Kotler et al.4 followed 162 patients less than 65 years of age and in New York Heart Association class I or II for 30 to 54 months. Complex PVCs were found to be an independent risk factor, and there were no differences between patients with Q wave and non-Q wave infarctions.
Again the discrepancy from the present study may be explained by the smaller number of patients, a younger age group with possibly less severe coronary heart disease, and a longer follow-up period. Kotler 90% of 81 patients with complex PVCs had ejection fractions of 0.40 or less. In the present study, only onethird of the patients in the non-Q wave infarction group with complex PVCs had ejection fractions of less than 45%, while in the Q wave group complex PVCs were equally distributed among those with fractions of greater or less than 45%.
Implications for treatment. Non-Q wave infarction is generally associated with a relatively small amount of necrosis and a low initial mortality when compared with Q wave infarctions."1 Despite the initial favorable prognosis, prospective follow-up in our patients has confirmed previous reports'8 '9 that the 1 to 2 year mortality for patients with non-Q wave infarctions is similar to and possibly greater than that for patients with Q wave infarctions. 21 The present study indicates that this late equalization of mortality may largely be due to the death of patients with non-Q wave infarcts who have complex PVCs. Although the mechanisms of late death in patients with non-Q wave infarctions is not known, Rigo et al. ,36 in a long-term study of 49 patients with non-Q wave and 111 patients with Q wave infarcts, suggested the possibility that patients with non-Q wave infarcts may have a higher incidence of fatal arrhythmias after discharge than patients with Q wave infarcts, based on a higher incidence of recurrent ischemia in the non-Q wave group. However, it is possible that the increased incidence of complex ventricular arrhythmias is causally unrelated to the increased late mortality in such patients with non-Q wave infarction, and that an unstable ischemic state2' with recurrent myocardial infarction is the cause. Nevertheless, it is also possible that death during recurrent ischemia or infarction occurs primarily in those with ongoing arrhythmias, or that primary arrhythmic death without concurrent ischemia occurs in some of these patients.
The best current evidence favors an independent association between ventricular arhythmias after myocardial infarction and subsequent mortality, and therefore it seems reasonable to recommend antiarrhythmic therapy in an effort to reduce this risk. To This group may provide one logical choice of patients in whom to test the efficacy of antiarrhythmic therapy in the setting of a randomized clinical trial.
